Home › Smoldering Multiple Myeloma › New Jersey
Smoldering Multiple Myeloma clinical trials in New Jersey
3 studies for Smoldering Multiple Myeloma are looking for participants at sites in New Jersey.
Cities in New Jersey
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Cooper Hospital University Medical Center, Camden
- Morristown Medical Center, Morristown
- Overlook Hospital, Summit
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT03937635A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT05640843A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Recruiting
Ages 18 and older · All sexes · Updated Nov 13, 2025 · NCT06055894From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.